Bruker introduces NMR test for Covid risk assessment
PhenoRisk PACS RuO enables quantitative multiplexed testing for the early detection of clinically well-characterised risk markers.

PhenoRisk PACS RuO enables quantitative multiplexed testing for the early detection of clinically well-characterised risk markers.
The merged company could become a leader in offering various neurovascular technologies and solutions globally.
Ivenix's infusion system was introduced last year after receiving US Food and Drug Administration (FDA) clearance.
The collaboration will provide access to pan-cancer biomarker testing for oncologists.
The new panels can detect RNA and DNA cancer biomarkers from formalin-fixed paraffin-embedded tissue specimens.
The PEEK filament can be processed in common extrusion-based 3D printing technologies, such as fused filament fabrication.
Austria, the UK, Italy, Turkey and Switzerland delivered significant gains during the period.
The ColoFuture study will assess the mRNA biomarkers’ effectiveness to improve the technical profile of the ColoAlert test.
Thank you for subscribing to Medical Device Network